Abstract
Description
Molecular diagnostics refers to the technique of identifying the presence of
any infection or disease, gene mutations, or any type of antigens attacking
the body, with the help of the genetic and protein activity patterns of the
body. Primarily, the molecular diagnostic tests are performed for three
purposes: diagnosis of the infectious diseases, genetic identification and the
diagnosis of genetic diseases. Currently, molecular diagnostics represent a
small share in the in-vitro diagnostics market, but it offers immense
opportunities for growth in future and therefore, is likely to drive the
in-vitro diagnostics market in the foreseeable future.
Diagnostic tests play an important role in helping the physicians in making
decisions, as it has been found that around 80% of the physicians' decisions
are based on the diagnostic reports. With the advent of faster and more
accurate molecular tests, coupled with the better sensitivity and specificity
of the molecular tests, there has been a shift from the traditional testing
methods towards the molecular diagnostic tests.
Presently, the molecular diagnostic market is growing on the back of oncology
and the infectious disease segment, but in future, when these segments are
likely to approach saturation, some of the other segments, including CT/GC,
HPV, HAI and Influenza are expected to offer opportunities for growth. The US,
Europe and Japan are the major markets for molecular diagnostic tests and
together account for a lion' s share in the global market. But in the coming
years, with the increasing per capita income, and rising concern regarding
healthy living in the emerging countries, like India and China, such countries
offer immense potential for growth.
Continuous innovation and the technological advancements are some of the
factors responsible for accelerating the growth of molecular diagnostic
market. However, some of the other major factors affecting the industry
include the increasing incidences of cancer, the rising number of cases of
hepatitis B and tuberculosis and the availability of various molecular
diagnostic tests.
The molecular diagnostics market is quite consolidated with the top seven
players holding major share of the market, including Roche, Novartis, Gen
Probe, QIAGEN, Bayer, Abbott, and Becton Dickinson.
The current report analyzes the molecular diagnostic market on the global
basis. It also presents a view of the various segments of the market. The
report discusses the drivers and challenges prevailing in the molecular
diagnostics industry. It presents the competitive conditions prevailing in the
global molecular diagnostic market, along with the profiles of four major
players in the industry, Roche, Gen-Probe, QIAGEN, and Bayer.
By combining SPSS Inc.' s data integration and analysis capabilities with our
relevant findings, we have predicted the future growth of the industry. We
employed various significant variables that have an impact on this industry
and created regression models with SPSS Base to determine the future direction
of the industry. Before deploying the regression model, the relationship
between several independent or predictor variables and the dependent variable
was analyzed using standard SPSS output, including charts, tables and tests.
Table of Contents
1. Introduction
- 1.1 In Vitro Diagnostics: Industry Overview
- 1.2 Molecular diagnostics
2. Global In-Vitro Diagnostics Market
- Market Value & Growth Rate
- Key Segments
3. Global Molecular Diagnostics Market
- 3.1 Market Size
- Market Share by Segments
- Market Share by Applications
- 3.2 Market Segments
- 3.2.1 Cancer
- 3.2.2 HPV (Human Papillomavirus)
- 3.2.3 Theranostics
4. Market Dynamics
- 4.1 Opportunities for Growth
- 4.1.1 CT/GC Market
- 4.1.2 HPV Tests
- 4.1.3 Hospital Acquired Infections (HAI)
- 4.1.4 Influenza Molecular Tests
- 4.1.5 Growth of Companion Diagnostic Tests
- 4.1.6 Growth in the Emerging Markets
- 4.2 Growth Drivers
- 4.2.1 Rapidly ageing Population
- 4.2.2 Shift towards Molecular Diagnostics
- 4.2.3 Rising Health Care Costs
- 4.2.4 High returns on investment (ROI)
5. Key Issues
- 5.1 Lack of Skilled Workforce
- 5.2 Complex Reimbursement Conditions
6. Competitive Landscape
- Competitive Overview
- Market Share
- Financial Comparison
7. Company Profiles
- 7.1 Roche Holdings AG
- Company Overview
- Key Financials
- Business Strategies
- Innovation to Tap Potential of Modern Science
- Providing Personalized Healthcare
- Focus on Unmet Medical Needs
- Increase in Research and Development
- 7.2 Gen-Probe
- Company Overview
- Key Financials
- Business Strategies
- Expansion through Acquisitions
- Increasing Commitment to Quality
- Focus on Innovation
- Marketing Strategy
- 7.3 QIAGEN
- Company Overview
- Key Financials
- Business Strategies
- Wide Geographical Presence
- Focus on Strategic Objectives
- Increasing Investment in Research and Development
- 7.4 Bayer AG
- Company Overview
- Key Financials
- Business Strategies
- Obtaining Leadership in all Segments
- Health Care Strategy
8. Market Outlook
- 8.1 Market Forecast
- 8.2 Forecast Methodology
- 8.2.1 Dependent and Independent Variables
- 8.2.2 Correlation Analysis
- 8.2.3 Regression Analysis
List of Charts
- IVD Market - Segments by Technology
- Molecular Diagnostcs - Traditional Process
- Main Purposes of Molecular Diagnostics
- Global IVD Market Size (2002-2009)
- Global IVD Market-by Clinical Segments (2009)
- Global IVD Market-Share by Segments (2014)
- Global Molecular Diagnostics Equipment Market (2003-2010E)
- Global Molecular Diagnostics Market-Share by Segments (2008)
- Global Molecular Diagnostics Market-Share by Application Areas (2010)
- Global Molecular Diagnostic Testing Market for Cancer (2001-2012)
- Global HPV Market-Value Share by Region (2009)
- Chinese HPV Market-Share by Companies (2009)
- Global Molecular Diagnostic Testing Market for Theranostics (2002-2012)
- CT/GC Revenue Share-by Major Companies (2007-2009)
- Ageing Population Worldwide (age>65) 2005-2015
- Cancer Costs-by Type (2010 & 2020)
- Worldwide Molecular Diagnostic Market-Share by Companies (2010)
- DNA Based Diagnostic Test Equipment Market-Share by Companies (2009)
- Roche Revenue (2006-2010)
- Roche Revenue-Share by Segments (2010)
- Roche/Genetech-Share of Projects in Research & Early Phase (Jan 2011)
- Roche and Genetech-Share of Projects in Phase III (Jan ' 11)
- Gen-Probe Revenue (2006-2010)
- Gen-Probe Revenue-by Sources (2010)
- QIAGEN Revenue (2006-2010)
- QIAGEN Revenue-Share by Source of Revenue (2010)
- QIAGEN Revenue-Share by Geographic Segments (2010)
- Bayer AG Revenue (2006-2010)
- Bayer AG Revenue-Share by Segments (2010)
- Global Molecular Diagnostics Market Forecast (2010 - 2014E)
List of Tables
- Top 10 Global IVD Market (2008 and 2015)
- National Limitation Amount for CPT Codes (2009-2010)
- US Molecular Testing Platforms-by Major Companies
- Financial Position of Key Players (2010)
- Dependent & Independent Variables (2003 - 2010)
- Correlation Matrix
- Model Summary - Coefficient of Determination
- Regression Coefficients Output
